MP CardioFlow Postpones Board Meeting to 31 Aug 2026 for Additional Lease-Related Review

Bulletin Express

Yesterday

MicroPort CardioFlow Medtech Corporation (MP CardioFlow) announced a rescheduling of its board meeting originally set for 26 August 2026. The session, convened to approve and publish the Group’s interim results for the six months ended 30 June 2026 and consider an interim dividend, will now take place on 31 August 2026.

According to the filing, the Board requires more time to compile and evaluate information related to the Group’s lease arrangements before finalising the 2026 Interim Results. No other changes to the agenda were disclosed.

The postponement notice was signed by Board Chairman Brian Chang on 26 August 2026 in Shanghai. The Board currently comprises three executive directors (Chen Guoming, Zhang Ruinian, Philippe Wanstok), two non-executive directors (Brian Chang, Deng Aoyi) and four independent non-executive directors (Jonathan H. Chou, Sun Zhixiang, Hu Bingshan, Mao Junxiang).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/news/1134167177"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1134167177\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1134167177?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 23:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134167177","market":"hk","top_or_hot":-1,"title":"MP CardioFlow Postpones Board Meeting to 31 Aug 2026 for Additional Lease-Related Review","media":"Bulletin Express","content":"<p>MicroPort CardioFlow Medtech Corporation (MP CardioFlow) announced a rescheduling of its board meeting originally set for 26 August 2026. The session, convened to approve and publish the Group’s interim results for the six months ended 30 June 2026 and consider an interim dividend, will now take place on 31 August 2026.</p>\n<p>According to the filing, the Board requires more time to compile and evaluate information related to the Group’s lease arrangements before finalising the 2026 Interim Results. No other changes to the agenda were disclosed.</p>\n<p>The postponement notice was signed by Board Chairman Brian Chang on 26 August 2026 in Shanghai. The Board currently comprises three executive directors (Chen Guoming, Zhang Ruinian, Philippe Wanstok), two non-executive directors (Brian Chang, Deng Aoyi) and four independent non-executive directors (Jonathan H. Chou, Sun Zhixiang, Hu Bingshan, Mao Junxiang).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MP CardioFlow Postpones Board Meeting to 31 Aug 2026 for Additional Lease-Related Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMP CardioFlow Postpones Board Meeting to 31 Aug 2026 for Additional Lease-Related Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-26 23:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MicroPort CardioFlow Medtech Corporation (MP CardioFlow) announced a rescheduling of its board meeting originally set for 26 August 2026. The session, convened to approve and publish the Group’s interim results for the six months ended 30 June 2026 and consider an interim dividend, will now take place on 31 August 2026.</p>\n<p>According to the filing, the Board requires more time to compile and evaluate information related to the Group’s lease arrangements before finalising the 2026 Interim Results. No other changes to the agenda were disclosed.</p>\n<p>The postponement notice was signed by Board Chairman Brian Chang on 26 August 2026 in Shanghai. The Board currently comprises three executive directors (Chen Guoming, Zhang Ruinian, Philippe Wanstok), two non-executive directors (Brian Chang, Deng Aoyi) and four independent non-executive directors (Jonathan H. Chou, Sun Zhixiang, Hu Bingshan, Mao Junxiang).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02160","symbol_name":"微创心通-B","start_time":0,"source_url":"","article_id":"1134167177","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134167177","pubTimestamp":1787756657,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"MicroPort CardioFlow Medtech Corporation (MP CardioFlow) announced a rescheduling of its board meeting originally set for 26 August 2026. The session, convened to approve and publish the Group’s...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02160":"微创心通-B"},"translate_title":"MP CardioFlow 将董事会会议推迟至 2026 年 8 月 31 日，以进行额外的租赁相关审查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02160":1},"content_text":"MicroPort CardioFlow Medtech Corporation (MP CardioFlow) announced a rescheduling of its board meeting originally set for 26 August 2026. The session, convened to approve and publish the Group’s interim results for the six months ended 30 June 2026 and consider an interim dividend, will now take place on 31 August 2026.\nAccording to the filing, the Board requires more time to compile and evaluate information related to the Group’s lease arrangements before finalising the 2026 Interim Results. No other changes to the agenda were disclosed.\nThe postponement notice was signed by Board Chairman Brian Chang on 26 August 2026 in Shanghai. The Board currently comprises three executive directors (Chen Guoming, Zhang Ruinian, Philippe Wanstok), two non-executive directors (Brian Chang, Deng Aoyi) and four independent non-executive directors (Jonathan H. Chou, Sun Zhixiang, Hu Bingshan, Mao Junxiang).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}